Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
Novartis Hrvatska D.O.O., a subsidiary of the global healthcare leader Novartis AG, is headquartered in Croatia (HR) and operates extensively across the region. Founded in 1996, the company has established itself in the pharmaceutical industry, focusing on innovative medicines and advanced therapies that address critical health challenges.
With a diverse portfolio that includes prescription medications, generics, and biosimilars, Novartis Hrvatska is renowned for its commitment to research and development. The company’s unique approach to drug discovery and patient care has positioned it as a key player in the Croatian market, contributing significantly to advancements in oncology, cardiology, and immunology.
Notable achievements include numerous awards for innovation and a strong reputation for quality, making Novartis Hrvatska a trusted name in healthcare.
+83 vs industry average
Novartis Hrvatska D.O.O.’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Food Product Manufacturing is among the most carbon-intensive industries
The Food Product Manufacturing industry has reduced its overall emissions by 22% since 2018
No reported emissions data is available for Novartis Hrvatska D.O.O. yet.
Novartis Hrvatska D.O.O. currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Novartis AG, which cascades its climate commitments and initiatives down to its subsidiaries.
Novartis AG has established various climate initiatives, including targets set through the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all of which are relevant to Novartis Hrvatska D.O.O. These initiatives aim to significantly reduce carbon emissions across their operations, although specific reduction targets for Novartis Hrvatska D.O.O. have not been detailed.
As part of its commitment to sustainability, Novartis AG has pledged to enhance its climate strategies, which include efforts to achieve net-zero emissions in the future. However, specific metrics or achievements related to emissions reductions for Novartis Hrvatska D.O.O. are not currently available.
In summary, while Novartis Hrvatska D.O.O. inherits its climate commitments from Novartis AG, detailed emissions data and specific reduction targets for the subsidiary remain unspecified.
Access structured emission data, company specific factors and auditable source documents
No climate goals have been disclosed for Novartis Hrvatska D.O.O. yet.
No scope 3 category breakdown has been disclosed yet.


No peer comparison is available for Novartis Hrvatska D.O.O. yet.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more